4-(4-Nitrophenyl)piperazin-1-ylethylamine → 3-{2-[4-(4-Nitrophenyl)piperazin-1-yl]ethyl}aminomethyl-1-phenyl-5-propylpyrazole
반응식
[N+:1]([C:4]1[CH:9]=[CH:8][C:7]([N:10]2[CH2:15][CH2:14][N:13]([CH2:16][CH2:17][NH2:18])[CH2:12][CH2:11]2)=[CH:6][CH:5]=1)([O-:3])=[O:2].[CH2:19]([C:22]1[N:26]([C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=2)[N:25]=[C:24]([CH:33]=O)[CH:23]=1)[CH2:20][CH3:21]>>[N+:1]([C:4]1[CH:5]=[CH:6][C:7]([N:10]2[CH2:11][CH2:12][N:13]([CH2:16][CH2:17][NH:18][CH2:33][C:24]3[CH:23]=[C:22]([CH2:19][CH2:20][CH3:21])[N:26]([C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=4)[N:25]=3)[CH2:14][CH2:15]2)=[CH:8][CH:9]=1)([O-:3])=[O:2]참가 물질
3
실험 절차
Compound 51 was prepared using the same method as that of Example 1 except that 4-(4-nitrophenyl)piperazin-1-ylethylamine and 5-propyl-1-phenylpyrazole-3-carbaldehyde were used.
출처 및 근거
- ORD 기록
- ord-f8a668205e60490fbffec328a82eaf51
- 출처 데이터셋
- uspto-grants-2009_06